您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Berotralstat
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Berotralstat
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Berotralstat图片
CAS NO:1809010-50-1
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
Berotralstat (BCX7353) 是一种低毒性,有效,高特异性,第二代,具有口服活性的 plasma kallikrein 抑制剂,用于遗传性血管水肿 (hereditary angioedema,HAE) 的研究。 Berotralstat 通过阻断 plasma kallikrein 释放缓激肽的酶活性来发挥作用,缓激肽是促进与 HAE 发作相关的肿胀和疼痛的主要生物肽。
Cas No.1809010-50-1
分子式C30H26F4N6O
分子量562.56
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Berotralstat (BCX7353) is a low toxicity, effective, highly specific, second-generation, synthetic and orally active plasma kallikrein inhibitor used for the research of hereditary angioedema (HAE) attacks. Berotralstat works by blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE[1][2].

[1]. Zuraw B, et al. Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial [published online ahead of print, 2020 Oct 21]. J Allergy Clin Immunol. 2020;S0091-6749(20)31484-6.
[2]. Manning ME, et al. Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies. Allergy Asthma Proc. 2021;42(4):274-282.